Therapies for Cancer Bring Hope and Failure


June 15, 2010

The New York Times

CHICAGO — The experimental drug PLX4032, which reverses the effects of a mutation found in certain tumors, is considered a prime example of the “targeted” cancer therapies of the future. The drug — the subject of a three-part series in The New York Times in February — produced seemingly miraculous results in some patients with melanoma... read more